How to use luspatercept and erythropoiesis-stimulating agents in low-risk myelodysplastic syndrome. Santini V, Consagra A. Br J Haematol 2025;207:15-26.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Santini V, Consagra A. How to use luspatercept and erythropoiesis-stimulating agents in low-risk myelodysplastic syndrome. Br J Haematol 2025;207:15-26.
PMID: 40318055